B'THETA Antibody

Shipped with Ice Packs
In Stock

Description

Key Antibody Clones and Targets

Monoclonal antibodies (mAbs) such as 3H2, 6E9, and 260.8 have been developed to study B. theta:

  • 3H2 and 6E9: Target surface antigens, including capsular polysaccharides (CPS) and outer membrane vesicles (OMVs). These mAbs localize B. theta in colonic tissues via immunofluorescence and ELISA .

  • 260.8: Binds to a conserved LPS O-antigen polysaccharide synthesis locus, enabling strain-specific identification of B. theta .

Antibody CloneTarget AntigenApplicationCitation
3H2, 6E9Surface CPS/OMV antigensImmunostaining, colitis studies
260.8LPS O-antigen polysaccharidesStrain-specific detection

Functional Roles in Immune Regulation

  • Sulfatase-Dependent Antigen Delivery: B. theta OMVs transport sulfatase-activated antigens to host immune cells (e.g., dendritic cells), triggering colitis in susceptible hosts . Antibodies like 3H2 track OMV localization in vivo.

  • IL-10 Induction: B. theta OMVs stimulate anti-inflammatory IL-10 production via TLR2 signaling, with antibodies used to isolate OMV-bound immunomodulatory factors .

  • Antigen-Specific T Cell Activation: Antibodies against B. theta surface antigens (e.g., BT4295 lipoprotein) reveal how bacterial load and CPS expression regulate T cell proliferation in germ-free (GF) vs. specific pathogen-free (SPF) mice .

Mechanisms of Immune Evasion

  • Capsular Polysaccharide Shielding: B. theta CPS blocks antibody-mediated antigen recognition. Strains expressing anti-stimulatory CPS evade immune detection unless antibodies engage Fc receptors to bypass this shielding .

  • Metabolic Adaptation: During colitis, B. theta downregulates ribosomal and metabolic genes while upregulating nutrient-uptake systems (e.g., starch utilization), altering antibody accessibility .

Research Applications

  • Colitis Models: Antibodies track B. theta colonization in genetically susceptible mice (e.g., dnKO or HLA-B27 Tg rats) .

  • OMV Studies: mAbs quantify sulfatase-dependent OMV uptake by immune cells .

  • Microbiota Competition Assays: Antibodies assess B. theta fitness against acapsular mutants in vitro and in vivo .

Critical Findings

  • CPS as a Virulence Factor: CPS-expressing B. theta outcompetes acapsular strains in vivo, resisting phagocytosis and antibiotic pressure .

  • IgA-Mediated Regulation: Host IgA targets conserved B. theta antigens (e.g., CPS), shaping microbial composition and metabolic activity .

Technical Considerations

  • Cross-Reactivity: Antibodies like 260.8 show high specificity for B. theta but not other Bacteroides species .

  • Antigen Load Sensitivity: Low B. theta colonization densities evade T cell activation unless amplified by adjuvants or overexpression .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
B'THETA antibody; At1g13460 antibody; T6J4.19Serine/threonine protein phosphatase 2A 57 kDa regulatory subunit B' theta isoform antibody; AtB' theta antibody; PP2A antibody; B' subunit antibody; theta isoform antibody
Target Names
B'THETA
Uniprot No.

Target Background

Function
The B regulatory subunit plays a crucial role in modulating substrate selectivity and catalytic activity of the enzyme. Furthermore, it may direct the localization of the catalytic enzyme to a specific subcellular compartment. It associates with the serine/threonine-protein phosphatase PP2A catalytic subunit C and regulatory subunit A. This association positively regulates beta-oxidation of fatty acids and protoauxins in peroxisomes by dephosphorylating peroxisomal beta-oxidation-related proteins. It is essential for the formation of the PP2A holoenzyme, which negatively regulates brassinosteroid signaling by dephosphorylating and inactivating BRI1 in the cytoplasm.
Database Links

KEGG: ath:AT1G13460

STRING: 3702.AT1G13460.1

UniGene: At.42029

Protein Families
Phosphatase 2A regulatory subunit B56 family
Subcellular Location
Cytoplasm, cytosol. Peroxisome.
Tissue Specificity
Highly expressed in dry seeds. Expressed in roots, cotyledons, rosette leaves and flowers.

Q&A

Basic Research Questions

  • What is Bacteroides thetaiotaomicron and why is it significant in gut microbiome research?

Bacteroides thetaiotaomicron (B. theta) is a highly abundant taxon in the human gut microbiome and a ubiquitous human symbiont that colonizes the host early in development and persists throughout the lifespan . This organism has garnered significant research interest due to its:

  • Remarkable metabolic versatility

  • Role as a keystone species in the gut ecosystem

  • Phenotypic plasticity in response to changing nutrient conditions

  • Complex interactions with the host immune system

B. theta demonstrates important metabolic adaptations, including prioritizing energy conservation when stressed by high acetate concentrations by suppressing secretion of "overflow metabolites" such as organic acids and amino acids . This metabolic flexibility contributes to its successful colonization and persistence in the dynamic gut environment.

  • What metabolites does B. theta secrete and how can they be detected in experimental settings?

B. theta secretes a diverse range of metabolites that can be identified through untargeted metabolomics approaches. The major secreted metabolites include:

Metabolite CategorySpecific Compounds
Organic AcidsAcetate, Succinate, Formate, Propionate, Lactate (minor)
Amino AcidsHistidine, Cysteine, Cystine (Cys-Cys disulfide), Glutathione, Asparagine, Alanine

These metabolites can be detected using one-dimensional proton nuclear magnetic resonance (1D 1H NMR) spectroscopy, which has evolved considerably in recent years, making untargeted NMR metabolomics of B. theta cultures feasible . When using this approach, researchers should consider that metabolite secretion patterns change significantly under different growth conditions - for instance, high acetate concentrations reduce the secretion of most metabolites while increasing succinate production .

  • How do B. theta-specific T cells respond differently in germ-free versus conventional mice?

T cells specifically recognizing B. theta antigens (BΘOM T cells) show dramatically different responses depending on the host's colonization status:

In germ-free (GF) mice:

  • B. theta colonization significantly increases the percentage of BΘOM T cells that divide

  • BΘOM T cells become activated and expand in both the spleen and mesenteric lymph nodes (mLN)

  • The response is robust compared to control mice

In specific pathogen-free (SPF) mice:

  • No significant effect of B. theta colonization on BΘOM T cell proliferation is observed

  • The T cell response is restricted despite successful colonization

  • This restriction appears to be independent of bacterial translocation, as similar numbers of bacteria reach the mLN in both GF and SPF mice initially

Importantly, this differential activation is specific to gut colonization, as both GF and SPF mice show similar BΘOM T cell activation patterns when challenged systemically with B. theta . This suggests local immune regulation in the gut of mice with established microbiota.

  • What factors influence B. theta antigen recognition by the immune system?

Several critical factors influence how B. theta antigens are recognized by the host immune system:

  • Bacterial density: High bacterial density is required to induce substantial T cell proliferation in germ-free mice

  • Antigen expression level: Even when bacterial numbers are high, reduced expression of specific antigens can limit T cell responses

  • Microbiota context: The presence of a complex microbiota in SPF mice restricts T cell responses to B. theta despite similar bacterial translocation

  • Capsular polysaccharides: Different capsular polysaccharides (CPS) on B. theta can modulate immune responses, with certain variants (particularly CPS5) correlating with higher amounts of secretory IgA in the gut

  • Metabolite secretion: B. theta-produced metabolites like succinate and propionate can impair host defense by inhibiting neutrophil functions

These factors should be carefully considered when designing experiments using B. theta as a model organism or when developing antibodies against it.

  • How can researchers identify specific B. theta strains using antibody-based techniques?

Highly specific antibody-based identification of B. theta strains requires careful consideration of target antigens and validation approaches:

Researchers have successfully developed monoclonal antibodies like mAb 260.8, which:

  • Recognize multiple isolates and strains of B. theta

  • Do not cross-react with other Bacteroides species

  • Target conserved structures necessary for colonization

The target identification process typically involves:

  • Isolating B cells from the lamina propria of mice mono-associated with B. theta

  • Generating hybridomas for monoclonal antibody production

  • Testing antibody specificity against multiple B. theta strains and other Bacteroides species

  • Using whole genome mutagenesis to identify the genetic loci encoding the target antigen

In the case of mAb 260.8, this approach identified a 19-gene locus involved in LPS O-antigen polysaccharide synthesis that is required for antibody reactivity . This demonstrates that carbohydrate structures, particularly those involved in colonization, can serve as highly specific targets for antibody-based detection.

Advanced Research Questions

  • How does metabolic feedback inhibition in B. theta affect its interaction with the host immune system?

B. theta exhibits sophisticated metabolic feedback mechanisms that not only alter its own physiology but also potentially modify its immunogenicity:

When exposed to high concentrations of acetate or formate, B. theta:

  • Experiences approximately 25% increased doubling time

  • Maintains similar final biomass yield

  • Significantly reduces secretion of organic acids and amino acids

  • Shows altered gene expression patterns that may influence surface antigen presentation

The microenvironment-dependent metabolic changes appear to be primarily due to kinetic biochemical feedback inhibition rather than altered ATP synthesis or metabolic efficiency . When metabolically stressed by acetate, B. theta prioritizes energy conservation and "stops sharing" metabolites with its ecological partners .

These metabolic adaptations likely have immunological consequences:

  • Changed surface antigen expression may alter antibody recognition

  • Reduced secretion of immunomodulatory metabolites may modify local immune responses

  • Metabolic stress may trigger expression of different capsular polysaccharide variants

Researchers developing antibodies against B. theta should therefore validate their specificity across different metabolic states to ensure consistent recognition.

  • What approaches can be used to develop highly specific monoclonal antibodies against B. theta?

Developing highly specific monoclonal antibodies against B. theta requires a strategic approach:

  • Target identification strategy:

    • Focus on conserved but species-specific structures

    • LPS O-antigen polysaccharides have proven to be excellent targets, as demonstrated by mAb 260.8

    • Capsular polysaccharides offer another potential target class that varies between species

  • Antibody development methods:

    • Classical hybridoma technology using B cells from animals exposed to B. theta

    • Novel antibody library design combining deep learning and multi-objective linear programming

    • Optimization for both intrinsic fitness (stability, developability) and extrinsic fitness (binding quality)

  • Validation protocol:

    • Test against multiple B. theta isolates (both hospital and community-acquired strains)

    • Cross-reactivity testing against other Bacteroides species

    • Functional validation in different experimental contexts (ELISA, immunofluorescence, flow cytometry)

    • Confirmation of specificity using genetic approaches (whole genome mutagenesis to identify target)

The dynamic weighting approach in antibody library design, where random weightings over objectives are sampled for each iteration, helps ensure diversity and coverage while mitigating the risk of over-optimizing for any individual parameter .

  • How can researchers optimize site-specific drug conjugation to anti-B. theta antibodies?

Site-specific drug conjugation to anti-B. theta antibodies offers several advantages over traditional conjugation methods, including improved homogeneity and control over the site of attachment:

Conjugation MethodMechanismAdvantagesConsiderations
Engineered Cysteine ResiduesIntroduction of cysteine residues at specific sites for selective targetingPrecise control of conjugation sitesMay affect antibody stability
Enzymatic ApproachesUsing enzymes like transglutaminase or sortase for site-specific attachmentMild reaction conditionsMay require specific recognition sequences
Unnatural Amino Acid IncorporationGenetic encoding of amino acids with bioorthogonal handlesHighly selective conjugationRequires specialized expression systems
Disulfide RebridgingControlled reduction and cross-linking of disulfide bondsMaintains structural integrityMay alter thermal stability

Site-specific conjugation methods have demonstrated improved in vivo performance compared to their non-specifically conjugated counterparts, with benefits including:

  • Enhanced pharmacokinetics

  • Reduced off-target toxicity

  • Improved therapeutic index

When applying these methods to anti-B. theta antibodies, researchers should carefully evaluate how the conjugation affects binding specificity, especially since B. theta presents a complex and variable surface antigen profile.

  • What role does the B. theta capsular polysaccharide play in antibody recognition and evasion?

The polysaccharide capsule of B. theta serves multiple functions that impact antibody recognition:

  • Acts as a protective barrier against attacks from other bacteria, bacteriophages, and the host immune system

  • Contains multiple capsular polysaccharide (CPS) variants, with certain types (particularly CPS5) correlating with higher amounts of secretory IgA in the gut

  • Can mask underlying cell surface antigens, potentially limiting antibody accessibility

  • May undergo phase variation, allowing for immune evasion through antigenic switching

For antibody development, researchers should consider:

  • Whether their target epitope is accessible in the presence of the capsule

  • If capsular switching might affect antibody recognition

  • The potential for using the capsule itself as a specific target

  • How growth conditions might affect capsular expression

Understanding the interactions between B. theta capsular polysaccharides and host antibodies is essential for developing effective detection tools and for studying host-microbe interactions in the gut ecosystem.

  • How can multi-objective optimization improve antibody library design for B. theta-specific antibodies?

Multi-objective optimization offers a sophisticated approach to designing antibody libraries specifically targeting B. theta:

  • Balancing multiple fitness parameters:

    • Extrinsic fitness: Optimizing binding specificity and affinity for B. theta antigens

    • Intrinsic fitness: Ensuring thermostability, developability, and manufacturability

    • This dual optimization reduces experimental failure risk by preventing overfitting to computational predictions

  • Implementation strategies:

    • Dynamic weighting approach: Sampling random weightings for each iteration rather than fixed weightings

    • Deep learning for initial candidate prediction

    • Multi-objective linear programming with diversity constraints for final library optimization

  • Diversity considerations:

    • The Pareto front (solutions where no objective can be improved without degrading another) often lacks sufficient diversity

    • Explicitly incorporating diversity constraints ensures broader coverage of potential solutions

  • Practical application for B. theta antibodies:

    • Can target multiple B. theta-specific epitopes simultaneously

    • Optimizes for recognition across different strains and growth conditions

    • Balances binding specificity with antibody stability and production characteristics

This approach is particularly valuable in a "zero-shot" setting where experimental fitness data is lacking, as is often the case when developing new antibodies against gut commensals like B. theta .

  • How does bacterial antigen load affect B. theta-specific T cell responses?

The relationship between B. theta antigen load and T cell responses reveals important principles about host-microbe immune interactions:

When manipulating antigen load by:

  • Diluting wild-type B. theta with a knockout strain lacking the specific T cell epitope (BT4295)

  • Creating a ratio of 1:10 between wild-type and knockout bacteria

  • Reducing the abundance of the epitope-carrying strain more than 10-fold

Researchers observed:

Similarly, increasing B. theta load in SPF mice through antibiotic pre-treatment:

  • Achieved almost 100-fold higher B. theta gut loads

  • Increased T cell division compared to controls

  • Still did not support substantial T cell expansion

These findings indicate a complex relationship between antigen dose and T cell fate, where:

  • A threshold level of antigen is required for initial T cell activation

  • Additional factors beyond antigen quantity are necessary for T cell survival and expansion

  • The host's microbial context significantly influences how T cells respond to specific bacterial antigens

  • What methodologies are most effective for studying B. theta metabolic adaptation and its impact on immunity?

To effectively study B. theta metabolic adaptation and its immunological consequences, researchers should employ a multi-faceted approach:

  • Metabolomics techniques:

    • Untargeted 1D 1H NMR spectroscopy provides comprehensive metabolite profiling

    • Allows identification of both expected and novel secreted metabolites

    • Can reveal how metabolic outputs change under different conditions

  • Experimental design considerations:

    • Culture B. theta under defined conditions with controlled nutrient availability

    • Systematically vary metabolite concentrations (e.g., acetate, formate) to observe feedback inhibition

    • Monitor growth parameters and pH changes alongside metabolite profiling

  • Systems biology approaches:

    • Integrate metabolomics data with transcriptomics and proteomics

    • Construct mathematical models to predict metabolic shifts

    • Account for both nutrient inputs and outputs to gain comprehensive insight

  • Immunological assays:

    • Use transgenic T cells (like BΘOM) to monitor specific immune responses

    • Examine how metabolic state affects antigen presentation and recognition

    • Study how B. theta-derived metabolites directly influence immune cell function

When B. theta is supplemented with acetate or formate, population doubling time increases by approximately 25%, yet biomass yield remains unchanged . These observations suggest that ATP synthesis and metabolic efficiency are not compromised, but rather kinetic biochemical feedback inhibition is the primary mechanism affecting growth. Understanding these adaptations is essential for interpreting how B. theta interacts with the host under different gut conditions.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.